The efficacy of Alahmady ring implantation in the management of neovascular glaucoma

Alahmady H Alsmman, Gamal Radwan, Mohammed Elagouz, Usama Ali Mohammed The Department of Ophthalmology, Sohag Faculty of Medicine, Sohag University, Sohag, Egypt Purpose: To evaluate the efficacy and safety of Alahmady ring implantation in the management of neovascular glaucoma.Methods: A total of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Alsmman AH, Radwan G, Elagouz M, Mohammed UA
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://doaj.org/article/371c869cdf2242cfb9db88ca8a018073
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:371c869cdf2242cfb9db88ca8a018073
record_format dspace
spelling oai:doaj.org-article:371c869cdf2242cfb9db88ca8a0180732021-12-02T00:30:10ZThe efficacy of Alahmady ring implantation in the management of neovascular glaucoma1177-5483https://doaj.org/article/371c869cdf2242cfb9db88ca8a0180732017-03-01T00:00:00Zhttps://www.dovepress.com/the-efficacy-of-alahmady-ring-implantation-in-the-management-of-neovas-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Alahmady H Alsmman, Gamal Radwan, Mohammed Elagouz, Usama Ali Mohammed The Department of Ophthalmology, Sohag Faculty of Medicine, Sohag University, Sohag, Egypt Purpose: To evaluate the efficacy and safety of Alahmady ring implantation in the management of neovascular glaucoma.Methods: A total of 15 eyes of 15 patients with intractable neovascular glaucoma with intraocular pressure (IOP) ≥28 mmHg not responding to medical treatment were retrospectively analyzed. All patients had poor visual acuity and underwent Alahmady ring implantation. The ring was designed from fenestrated silicon tube used in lacrimal surgeries and was implanted subsclerally after passing it through the anterior chamber. Patients were followed up for at least 24 months. Success in this study was defined based on IOP ≥8 mmHg and <21 mmHg, with not more than 1 glaucoma drug, and improvement of patient symptoms and signs with maximum use of beta blocker as antiglaucoma drug.Results: A total of 15 eyes of 15 patients (9 males [60%] and 6 females [40%]) were analyzed in this study. The mean IOP before surgery was 38.6 mmHg (standard deviation [SD]: 6.98) and it was 14.05 mmHg (SD =7.57) after surgery. The follow-up range was 24–36 months. Success of silicon drainage device was defined as an IOP <21 mmHg on the last follow-up visit. Medications included only beta-blockers and topical steroids for those who were without severe complications or for those who were not in a condition to undergo a further glaucoma surgery.Conclusion: Alahmady ring implantation proves to be a good surgical option for neovascular glaucoma; however, a longer follow-up period is recommended. Keywords: refractory glaucoma, glaucoma device, failed trabeculectomyAlsmman AHRadwan GElagouz MMohammed UADove Medical PressarticleAlahmady ringglaucoma deviceneovascular glaucomaOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 11, Pp 541-548 (2017)
institution DOAJ
collection DOAJ
language EN
topic Alahmady ring
glaucoma device
neovascular glaucoma
Ophthalmology
RE1-994
spellingShingle Alahmady ring
glaucoma device
neovascular glaucoma
Ophthalmology
RE1-994
Alsmman AH
Radwan G
Elagouz M
Mohammed UA
The efficacy of Alahmady ring implantation in the management of neovascular glaucoma
description Alahmady H Alsmman, Gamal Radwan, Mohammed Elagouz, Usama Ali Mohammed The Department of Ophthalmology, Sohag Faculty of Medicine, Sohag University, Sohag, Egypt Purpose: To evaluate the efficacy and safety of Alahmady ring implantation in the management of neovascular glaucoma.Methods: A total of 15 eyes of 15 patients with intractable neovascular glaucoma with intraocular pressure (IOP) ≥28 mmHg not responding to medical treatment were retrospectively analyzed. All patients had poor visual acuity and underwent Alahmady ring implantation. The ring was designed from fenestrated silicon tube used in lacrimal surgeries and was implanted subsclerally after passing it through the anterior chamber. Patients were followed up for at least 24 months. Success in this study was defined based on IOP ≥8 mmHg and <21 mmHg, with not more than 1 glaucoma drug, and improvement of patient symptoms and signs with maximum use of beta blocker as antiglaucoma drug.Results: A total of 15 eyes of 15 patients (9 males [60%] and 6 females [40%]) were analyzed in this study. The mean IOP before surgery was 38.6 mmHg (standard deviation [SD]: 6.98) and it was 14.05 mmHg (SD =7.57) after surgery. The follow-up range was 24–36 months. Success of silicon drainage device was defined as an IOP <21 mmHg on the last follow-up visit. Medications included only beta-blockers and topical steroids for those who were without severe complications or for those who were not in a condition to undergo a further glaucoma surgery.Conclusion: Alahmady ring implantation proves to be a good surgical option for neovascular glaucoma; however, a longer follow-up period is recommended. Keywords: refractory glaucoma, glaucoma device, failed trabeculectomy
format article
author Alsmman AH
Radwan G
Elagouz M
Mohammed UA
author_facet Alsmman AH
Radwan G
Elagouz M
Mohammed UA
author_sort Alsmman AH
title The efficacy of Alahmady ring implantation in the management of neovascular glaucoma
title_short The efficacy of Alahmady ring implantation in the management of neovascular glaucoma
title_full The efficacy of Alahmady ring implantation in the management of neovascular glaucoma
title_fullStr The efficacy of Alahmady ring implantation in the management of neovascular glaucoma
title_full_unstemmed The efficacy of Alahmady ring implantation in the management of neovascular glaucoma
title_sort efficacy of alahmady ring implantation in the management of neovascular glaucoma
publisher Dove Medical Press
publishDate 2017
url https://doaj.org/article/371c869cdf2242cfb9db88ca8a018073
work_keys_str_mv AT alsmmanah theefficacyofalahmadyringimplantationinthemanagementofneovascularglaucoma
AT radwang theefficacyofalahmadyringimplantationinthemanagementofneovascularglaucoma
AT elagouzm theefficacyofalahmadyringimplantationinthemanagementofneovascularglaucoma
AT mohammedua theefficacyofalahmadyringimplantationinthemanagementofneovascularglaucoma
AT alsmmanah efficacyofalahmadyringimplantationinthemanagementofneovascularglaucoma
AT radwang efficacyofalahmadyringimplantationinthemanagementofneovascularglaucoma
AT elagouzm efficacyofalahmadyringimplantationinthemanagementofneovascularglaucoma
AT mohammedua efficacyofalahmadyringimplantationinthemanagementofneovascularglaucoma
_version_ 1718403668684832768